 William Woodward
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Stress | 4 | 2025 | 29 | 2.010 |
Why?
| | Sympathetic Nervous System | 13 | 2024 | 180 | 1.610 |
Why?
| | Norepinephrine | 14 | 2024 | 196 | 1.520 |
Why?
| | Myocardial Infarction | 8 | 2025 | 1209 | 1.000 |
Why?
| | Coronary Artery Disease | 5 | 2025 | 743 | 0.950 |
Why?
| | Methoxyhydroxyphenylglycol | 3 | 2024 | 13 | 0.760 |
Why?
| | Heart | 9 | 2026 | 626 | 0.610 |
Why?
| | Schools | 2 | 2019 | 450 | 0.570 |
Why?
| | Electrochemical Techniques | 1 | 2018 | 55 | 0.530 |
Why?
| | Psychology | 2 | 2010 | 88 | 0.500 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2018 | 580 | 0.490 |
Why?
| | Students | 2 | 2019 | 657 | 0.480 |
Why?
| | Action Potentials | 3 | 2024 | 502 | 0.470 |
Why?
| | Violence | 1 | 2019 | 279 | 0.450 |
Why?
| | Tyrosine 3-Monooxygenase | 9 | 2019 | 72 | 0.430 |
Why?
| | Chest Pain | 2 | 2025 | 99 | 0.380 |
Why?
| | Cytokine Receptor gp130 | 4 | 2016 | 10 | 0.370 |
Why?
| | Neurons | 6 | 2016 | 1639 | 0.370 |
Why?
| | Ganglia, Sympathetic | 2 | 2016 | 14 | 0.360 |
Why?
| | Hypertension | 4 | 2024 | 1262 | 0.340 |
Why?
| | Heart Failure | 5 | 2024 | 2324 | 0.340 |
Why?
| | Norepinephrine Plasma Membrane Transport Proteins | 3 | 2007 | 6 | 0.320 |
Why?
| | Judaism | 1 | 2010 | 2 | 0.320 |
Why?
| | Emigration and Immigration | 1 | 2010 | 66 | 0.300 |
Why?
| | Catecholamines | 3 | 2006 | 87 | 0.290 |
Why?
| | Receptors, Nerve Growth Factor | 3 | 2013 | 18 | 0.280 |
Why?
| | Neurotransmitter Agents | 2 | 2012 | 83 | 0.270 |
Why?
| | Heart Ventricles | 4 | 2017 | 751 | 0.270 |
Why?
| | Cell Transdifferentiation | 2 | 2020 | 31 | 0.270 |
Why?
| | Electroretinography | 1 | 2007 | 50 | 0.260 |
Why?
| | Xylazine | 1 | 2007 | 15 | 0.260 |
Why?
| | Myocardium | 4 | 2026 | 928 | 0.260 |
Why?
| | Ethnopsychology | 1 | 2007 | 6 | 0.260 |
Why?
| | Isoflurane | 1 | 2007 | 41 | 0.250 |
Why?
| | United Kingdom | 2 | 2025 | 337 | 0.250 |
Why?
| | Social Change | 1 | 2007 | 15 | 0.250 |
Why?
| | Behavioral Research | 1 | 2007 | 35 | 0.250 |
Why?
| | Population Groups | 1 | 2007 | 56 | 0.250 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2026 | 24 | 0.240 |
Why?
| | Anesthetics | 1 | 2007 | 99 | 0.240 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2016 | 139 | 0.240 |
Why?
| | Ketamine | 1 | 2007 | 133 | 0.240 |
Why?
| | Culture | 1 | 2007 | 125 | 0.240 |
Why?
| | Community Participation | 1 | 2007 | 122 | 0.230 |
Why?
| | Vulnerable Populations | 1 | 2007 | 175 | 0.230 |
Why?
| | Sympathectomy | 2 | 2017 | 6 | 0.230 |
Why?
| | Cachexia | 1 | 2026 | 74 | 0.220 |
Why?
| | Mice, Inbred C57BL | 10 | 2026 | 5967 | 0.220 |
Why?
| | Historiography | 1 | 2004 | 1 | 0.220 |
Why?
| | Health Services Research | 1 | 2007 | 392 | 0.210 |
Why?
| | Angiotensin II | 1 | 2024 | 95 | 0.210 |
Why?
| | Anesthesia | 1 | 2007 | 258 | 0.200 |
Why?
| | Dobutamine | 2 | 2022 | 24 | 0.200 |
Why?
| | Postnatal Care | 1 | 2023 | 76 | 0.190 |
Why?
| | Aromatic-L-Amino-Acid Decarboxylases | 1 | 2002 | 2 | 0.190 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 67 | 0.190 |
Why?
| | Pterins | 1 | 2002 | 7 | 0.190 |
Why?
| | N-Acetylgalactosamine-4-Sulfatase | 1 | 2022 | 3 | 0.180 |
Why?
| | Self-Management | 2 | 2023 | 201 | 0.180 |
Why?
| | Exercise Test | 2 | 2023 | 626 | 0.180 |
Why?
| | Arrhythmias, Cardiac | 3 | 2024 | 355 | 0.180 |
Why?
| | Acetylcholine | 4 | 2016 | 208 | 0.180 |
Why?
| | Blood Pressure | 3 | 2023 | 1766 | 0.180 |
Why?
| | Calcium Signaling | 2 | 2024 | 243 | 0.180 |
Why?
| | Heart Rate | 3 | 2024 | 853 | 0.180 |
Why?
| | History, 20th Century | 3 | 2010 | 327 | 0.180 |
Why?
| | Fatigue | 1 | 2024 | 363 | 0.180 |
Why?
| | Sulfur | 1 | 2022 | 64 | 0.170 |
Why?
| | Nicotine | 1 | 2024 | 334 | 0.170 |
Why?
| | Myocardial Ischemia | 1 | 2023 | 285 | 0.170 |
Why?
| | Parasympathetic Nervous System | 3 | 2013 | 26 | 0.170 |
Why?
| | Male | 20 | 2026 | 72431 | 0.160 |
Why?
| | Mice | 16 | 2026 | 18261 | 0.160 |
Why?
| | Oxygen Consumption | 1 | 2023 | 717 | 0.150 |
Why?
| | Cholinergic Neurons | 1 | 2020 | 18 | 0.150 |
Why?
| | Female | 20 | 2025 | 78304 | 0.150 |
Why?
| | Ciliary Neurotrophic Factor | 3 | 2012 | 12 | 0.150 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2019 | 9 | 0.150 |
Why?
| | Antihypertensive Agents | 1 | 2023 | 512 | 0.150 |
Why?
| | Frailty | 1 | 2023 | 200 | 0.150 |
Why?
| | Animals | 22 | 2026 | 37948 | 0.150 |
Why?
| | Aged | 7 | 2025 | 25955 | 0.150 |
Why?
| | Humans | 20 | 2025 | 144667 | 0.140 |
Why?
| | Risk Assessment | 2 | 2025 | 3729 | 0.140 |
Why?
| | Sympathetic Fibers, Postganglionic | 2 | 2011 | 4 | 0.130 |
Why?
| | Auditory Cortex | 1 | 2018 | 46 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2026 | 926 | 0.130 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2018 | 64 | 0.130 |
Why?
| | Sex Factors | 2 | 2024 | 2104 | 0.130 |
Why?
| | Torso | 1 | 2017 | 37 | 0.130 |
Why?
| | Heart Atria | 3 | 2013 | 141 | 0.130 |
Why?
| | Photography | 1 | 2017 | 119 | 0.120 |
Why?
| | Tinnitus | 1 | 2018 | 68 | 0.120 |
Why?
| | Prospective Studies | 3 | 2025 | 7994 | 0.120 |
Why?
| | Safety | 1 | 2018 | 356 | 0.120 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5414 | 0.110 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4539 | 0.110 |
Why?
| | Dopamine beta-Hydroxylase | 2 | 2016 | 13 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.100 |
Why?
| | Rats | 7 | 2022 | 5570 | 0.100 |
Why?
| | Thioctic Acid | 1 | 2014 | 12 | 0.100 |
Why?
| | Electrocardiography | 1 | 2017 | 664 | 0.100 |
Why?
| | Time Factors | 1 | 2025 | 7140 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 581 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 392 | 0.100 |
Why?
| | Mice, Knockout | 7 | 2020 | 3109 | 0.100 |
Why?
| | Heart Injuries | 1 | 2013 | 42 | 0.100 |
Why?
| | Heart-Assist Devices | 1 | 2019 | 568 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 949 | 0.100 |
Why?
| | Aging | 2 | 2008 | 1938 | 0.100 |
Why?
| | Chondroitin Sulfate Proteoglycans | 2 | 2023 | 10 | 0.100 |
Why?
| | Alzheimer Disease | 2 | 2014 | 622 | 0.090 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 141 | 0.090 |
Why?
| | Coronary Angiography | 2 | 2025 | 324 | 0.090 |
Why?
| | Cicatrix | 2 | 2023 | 69 | 0.090 |
Why?
| | Middle Aged | 6 | 2025 | 35971 | 0.090 |
Why?
| | Heart Conduction System | 1 | 2012 | 96 | 0.090 |
Why?
| | Diet, High-Fat | 1 | 2013 | 261 | 0.090 |
Why?
| | Qualitative Research | 1 | 2019 | 1668 | 0.080 |
Why?
| | Gestalt Theory | 1 | 2010 | 2 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2012 | 762 | 0.080 |
Why?
| | Russia | 1 | 2010 | 13 | 0.080 |
Why?
| | Cytokines | 3 | 2009 | 2045 | 0.080 |
Why?
| | Up-Regulation | 3 | 2011 | 848 | 0.080 |
Why?
| | Rabbits | 2 | 2024 | 651 | 0.070 |
Why?
| | Kidney | 1 | 2017 | 1495 | 0.070 |
Why?
| | Faculty | 1 | 2010 | 153 | 0.070 |
Why?
| | Sodium | 1 | 2009 | 198 | 0.070 |
Why?
| | Receptor, Nerve Growth Factor | 1 | 2008 | 3 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2006 | 4110 | 0.070 |
Why?
| | Choline O-Acetyltransferase | 2 | 2020 | 26 | 0.070 |
Why?
| | Adaptation, Ocular | 1 | 2007 | 6 | 0.070 |
Why?
| | Dark Adaptation | 1 | 2007 | 13 | 0.070 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2007 | 17 | 0.070 |
Why?
| | Artificial Intelligence | 2 | 2023 | 381 | 0.060 |
Why?
| | Universities | 1 | 2010 | 452 | 0.060 |
Why?
| | Oscillometry | 1 | 2007 | 35 | 0.060 |
Why?
| | Vision, Ocular | 1 | 2007 | 47 | 0.060 |
Why?
| | Anesthetics, Dissociative | 1 | 2007 | 46 | 0.060 |
Why?
| | Western World | 1 | 2007 | 7 | 0.060 |
Why?
| | History, 19th Century | 1 | 2007 | 63 | 0.060 |
Why?
| | Anesthetics, Inhalation | 1 | 2007 | 52 | 0.060 |
Why?
| | Stroke Volume | 2 | 2023 | 650 | 0.060 |
Why?
| | Knowledge | 1 | 2007 | 57 | 0.060 |
Why?
| | Japan | 1 | 2007 | 145 | 0.060 |
Why?
| | Quality of Life | 1 | 2019 | 3183 | 0.060 |
Why?
| | Biomarkers | 3 | 2024 | 4261 | 0.060 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2026 | 9 | 0.060 |
Why?
| | Metoprolol | 1 | 2026 | 26 | 0.060 |
Why?
| | Potassium Chloride | 1 | 2006 | 40 | 0.060 |
Why?
| | Blotting, Western | 2 | 2012 | 1161 | 0.060 |
Why?
| | Pregnancy | 3 | 2023 | 7122 | 0.060 |
Why?
| | Social Support | 1 | 2010 | 650 | 0.060 |
Why?
| | United States | 3 | 2010 | 16018 | 0.060 |
Why?
| | Ventricular Function, Left | 2 | 2024 | 536 | 0.050 |
Why?
| | Stellate Ganglion | 2 | 2019 | 8 | 0.050 |
Why?
| | Retina | 1 | 2007 | 319 | 0.050 |
Why?
| | Czechoslovakia | 1 | 2004 | 1 | 0.050 |
Why?
| | Developing Countries | 1 | 2007 | 317 | 0.050 |
Why?
| | Isolated Heart Preparation | 1 | 2024 | 6 | 0.050 |
Why?
| | Transdermal Patch | 1 | 2024 | 15 | 0.050 |
Why?
| | Administration, Cutaneous | 1 | 2024 | 126 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2007 | 374 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2007 | 2815 | 0.050 |
Why?
| | History, 21st Century | 1 | 2004 | 220 | 0.050 |
Why?
| | State Medicine | 1 | 2023 | 26 | 0.050 |
Why?
| | Reperfusion | 1 | 2023 | 54 | 0.050 |
Why?
| | Myostatin | 1 | 2023 | 24 | 0.050 |
Why?
| | Sweat Glands | 1 | 2002 | 5 | 0.050 |
Why?
| | Tissue Extracts | 1 | 2002 | 19 | 0.050 |
Why?
| | Amyloidosis | 1 | 2003 | 44 | 0.050 |
Why?
| | Pteridines | 1 | 2002 | 22 | 0.050 |
Why?
| | Nicotinic Agonists | 1 | 2024 | 138 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2006 | 820 | 0.050 |
Why?
| | Cell Polarity | 1 | 2003 | 137 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 547 | 0.040 |
Why?
| | Nerve Regeneration | 1 | 2022 | 58 | 0.040 |
Why?
| | Mice, Transgenic | 3 | 2016 | 2184 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 360 | 0.040 |
Why?
| | Proteoglycans | 1 | 2022 | 110 | 0.040 |
Why?
| | Foot | 1 | 2002 | 101 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 3 | 2013 | 2521 | 0.040 |
Why?
| | Pre-Eclampsia | 1 | 2023 | 203 | 0.040 |
Why?
| | Adiponectin | 1 | 2023 | 240 | 0.040 |
Why?
| | Disease Management | 1 | 2025 | 650 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2023 | 317 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2003 | 243 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2003 | 503 | 0.040 |
Why?
| | Antigens | 1 | 2022 | 347 | 0.040 |
Why?
| | Adrenergic Neurons | 1 | 2020 | 7 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2022 | 11735 | 0.040 |
Why?
| | Dopamine | 1 | 2002 | 291 | 0.040 |
Why?
| | Obesity | 1 | 2013 | 3070 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1811 | 0.040 |
Why?
| | Ischemia | 1 | 2023 | 422 | 0.040 |
Why?
| | Rats, Inbred WKY | 1 | 2019 | 35 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2003 | 470 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 368 | 0.040 |
Why?
| | Echocardiography | 1 | 2021 | 644 | 0.040 |
Why?
| | Tyramine | 2 | 2008 | 8 | 0.030 |
Why?
| | Synaptic Transmission | 2 | 2012 | 292 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3523 | 0.030 |
Why?
| | Genotype | 2 | 2016 | 1847 | 0.030 |
Why?
| | Skin | 1 | 2002 | 762 | 0.030 |
Why?
| | Electrodes | 1 | 2017 | 112 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1569 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2591 | 0.030 |
Why?
| | Observer Variation | 1 | 2017 | 355 | 0.030 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2922 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2117 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2017 | 449 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1742 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2016 | 278 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3888 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 555 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 3147 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2014 | 20 | 0.030 |
Why?
| | Mental Status Schedule | 1 | 2014 | 35 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 779 | 0.020 |
Why?
| | Adult | 3 | 2023 | 40489 | 0.020 |
Why?
| | Epinephrine | 1 | 2013 | 154 | 0.020 |
Why?
| | Signal Transduction | 1 | 2026 | 5185 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2172 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6399 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5870 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1301 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2183 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2014 | 441 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 539 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2014 | 2033 | 0.020 |
Why?
| | Brain Stem | 1 | 2009 | 97 | 0.020 |
Why?
| | Transgenes | 1 | 2009 | 191 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5957 | 0.020 |
Why?
| | Growth Cones | 1 | 2008 | 6 | 0.020 |
Why?
| | Neurotrophin 3 | 1 | 2008 | 10 | 0.020 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2008 | 14 | 0.020 |
Why?
| | Nerve Growth Factor | 1 | 2008 | 34 | 0.020 |
Why?
| | Tachycardia | 1 | 2008 | 57 | 0.020 |
Why?
| | Angiotensinogen | 1 | 2007 | 4 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1886 | 0.020 |
Why?
| | Sympathomimetics | 1 | 2007 | 19 | 0.020 |
Why?
| | Ligation | 1 | 2007 | 91 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1704 | 0.020 |
Why?
| | Adrenergic beta-Agonists | 1 | 2007 | 92 | 0.020 |
Why?
| | Presynaptic Terminals | 1 | 2008 | 89 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2754 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2007 | 245 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2007 | 288 | 0.010 |
Why?
| | Young Adult | 1 | 2023 | 14122 | 0.010 |
Why?
| | Coronary Vessels | 1 | 2007 | 246 | 0.010 |
Why?
| | Leukemia Inhibitory Factor | 1 | 2003 | 5 | 0.010 |
Why?
| | GTP Cyclohydrolase | 1 | 2003 | 10 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2003 | 39 | 0.010 |
Why?
| | Lymphokines | 1 | 2003 | 128 | 0.010 |
Why?
| | Symporters | 1 | 2003 | 48 | 0.010 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2003 | 64 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 973 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8284 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 2037 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 338 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2008 | 1148 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2003 | 854 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2003 | 770 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22409 | 0.010 |
Why?
| | Child | 1 | 2018 | 22600 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1207 | 0.010 |
Why?
| | Hippocampus | 1 | 2003 | 966 | 0.010 |
Why?
| | Inflammation | 1 | 2003 | 2870 | 0.010 |
Why?
|
|
Woodward's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|